Skip to main content
TISSUE REGENIX GROUP PLC logo

TISSUE REGENIX GROUP PLC — Investor Relations & Filings

Ticker · TRX ISIN · GB00BNTXR104 LEI · 213800PNOD5UHQUFJI36 IL Manufacturing
Open in API
Filings indexed 426 across all filing types
Latest filing 2026-02-23 Regulatory Filings
Country GB United Kingdom
Listing IL TRX

About TISSUE REGENIX GROUP PLC

https://www.tissueregenix.com/

Tissue Regenix Group PLC is a medical technology company specializing in regenerative medicine. The company develops and commercializes biological products designed to repair and regenerate human tissue. It employs proprietary decellularization platform technologies to process human and animal tissues, creating acellular scaffolds. When implanted, these scaffolds support the patient's own cells in repopulating and regenerating the damaged area. The company's portfolio serves three main clinical areas: biosurgery for complex wound care, orthopaedics for sports medicine and bone graft substitutes, and dental applications for tissue and bone repair. Key products include DermaPure®, OrthoPure® XT, and the Matrix® line of bone graft substitutes.

Recent filings

Filing Released Lang Actions
First Asset Match auction nearing close
Regulatory Filings Classification · 100% confidence The document is a regulatory news service (RNS) announcement from Tissue Regenix Group PLC dated 23 February 2026. It discusses the upcoming close of the first Asset Match auction for trading the company's shares following cancellation from trading on AIM. The text explains the trading mechanism via Asset Match, a regulated off-market dealing facility, and provides contact information for further inquiries. There are no financial statements, detailed financial results, or management analysis present. The document is relatively short (4586 characters) and serves as an update on trading arrangements rather than a financial report or detailed investor presentation. It does not contain any voting results, board changes, or legal proceedings. It is an official regulatory announcement about trading arrangements, fitting best under the category of Regulatory Filings (RNS).
2026-02-23 English
Update re. review of previous financial position
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Tissue Regenix Group PLC regarding an internal investigation into corporate governance concerns and financial reporting issues. It does not fit into specific categories like financial results, dividends, or director dealings. As it is a general regulatory announcement regarding company operations and governance investigations, it falls under the RNS (Regulatory Filings) category.
2026-01-16 English
Secondary Trading Following Cancellation
Regulatory Filings Classification · 95% confidence The document is an announcement from Tissue Regenix Group plc regarding the secondary market trading facility following the cancellation of its admission to trading on AIM. It details the operational aspects of the new trading platform (Asset Match) and provides contact information and background about the company. There are no financial statements, no detailed financial performance data, nor any regulatory filings or certifications. The document is an official notice about a change in trading status and market facility, which fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like Delisting Announcement (DLST) because it focuses on secondary trading arrangements post-cancellation rather than the cancellation itself. The document length is moderate and contains substantive information about the trading facility, not just a brief report publication announcement. Therefore, the best classification is Regulatory Filings (RNS).
2026-01-07 English
Result of General Meeting and Cancellation
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is an official announcement of the results of a General Meeting, specifically detailing the proxy votes for various resolutions. It also includes a section on the cancellation of the company's admission to trading on AIM. While it contains voting results (DVA), the document also explicitly announces a delisting (DLST). Given the primary focus on the outcome of the General Meeting and the subsequent corporate actions, 'DVA' is the most accurate classification for the voting results, but since the document covers multiple regulatory events including delisting, 'DVA' remains the most specific category for the meeting results provided.
2025-12-22 English
Update re. proposed cancellation of shares
Regulatory Filings Classification · 98% confidence The document is an official announcement from Tissue Regenix Group plc regarding the proposed cancellation of its shares from trading and the subsequent implementation of a matched bargain facility. It explicitly references a previous announcement and provides updates on the company's trading status and financial position. Since the document is a short regulatory announcement regarding the status of the company's listing and shares, it falls under the 'Delisting Announcement' category.
2025-12-08 English
Proposed £17.5m CLN raise, cancellation of Trading
Regulatory Filings Classification · 98% confidence The document is a formal announcement from Tissue Regenix Group PLC regarding a proposed fundraising (Secured Convertible Loan Notes), a delisting from AIM, and a re-registration as a private company. It includes a notice of a General Meeting to vote on these resolutions. While it contains significant details, it functions as a regulatory announcement (RNS) notifying the market of these corporate actions and the publication of a circular. It fits the 'Regulatory Filings' (RNS) category as it is a formal market announcement of multiple corporate events including delisting and financing.
2025-12-04 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.